Icosavax, Inc. (ICVX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Icosavax, Inc., with annual and quarterly history.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -3.57x | -6.05x | -5.25x | -68.92x |
| P/B Ratio | 1.45x | 1.48x | -3.77x | -43.44x |
| P/S Ratio | 541.95x | 52.69x | 62.28x | 0.00x |
| Profitability | ||||
| Gross Margin | -216.7% | 98.9% | -993.3% | 0.0% |
| Operating Margin | -16333.0% | -844.2% | -1157.8% | 0.0% |
| Net Margin | -15199.0% | -871.6% | -1187.2% | 0.0% |
| EBITDA Margin | -16185.2% | -831.9% | -1146.2% | 0.0% |
| Liquidity | ||||
| Current Ratio | 16.24x | 31.02x | 2.77x | 19.04x |
| Quick Ratio | 16.24x | 31.02x | 2.77x | 19.04x |
| Leverage | ||||
| Debt/Equity | 0.04x | 0.00x | -0.19x | 0.00x |
YoY = year-over-year change. Source: FMP..